2016
DOI: 10.1016/j.jaubas.2015.08.001
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, characterization and in vitro drug release of cisplatin loaded Cassava starch acetate–PEG/gelatin nanocomposites

Abstract: The aim of the present study is to examine the feasibility of Cassava starch acetate (CSA)-polyethylene glycol (PEG)-gelatin (G) nanocomposites as controlled drug delivery systems. It is one of the novel drug vehicles which can be used for the controlled release of an anticancer drug. Simple nano precipitation method was used to prepare the carriers CSA-PEG-G nanocomposites and they were used for entrapping cisplatin (CDDP). Through FT-IR spectroscopy, the linking among various components of the system was pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
23
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(24 citation statements)
references
References 40 publications
1
23
0
Order By: Relevance
“…Raj et al investigated the possibility of utilizing cisplatin-loaded cassava starch acetate-polyethylene glycol (PEG)-gelatin nanocomposite for anticancer drug delivery [129]. The nanocomposite drug release system was based on pH and time.…”
Section: Drug Delivery and Nanomedicinementioning
confidence: 99%
“…Raj et al investigated the possibility of utilizing cisplatin-loaded cassava starch acetate-polyethylene glycol (PEG)-gelatin nanocomposite for anticancer drug delivery [129]. The nanocomposite drug release system was based on pH and time.…”
Section: Drug Delivery and Nanomedicinementioning
confidence: 99%
“…The most important issue is the parameter k 2[S] that may be seen as the rate limiting factor. This factor should be seen to be important in the clearance of starch or modified starch from starch or modified starch based encapsulating agents [41][42][43] for therapeutic drug delivery to target tissue and organ. Although k 2 may appear to be sufficient in monitoring the rate of production of reducing sugar, but the means to an end could be more important.…”
Section: Resultsmentioning
confidence: 99%
“…Cisplatin is used to treat tumors in various parts of the body such as the head, neck, respiratory, digestive, and renal systems [ 127 , 128 ]. The clinical application of CDDP for cancer chemotherapy is still in limited because of its nonspecific bio-distribution and severe side effects [ 129 ]. Raj studied encapsulation of the anticancer drug CDDP into cassava starch acetate/polyethylene glycol/gelatin (CSA/PEG/G) nanocomposites through the interaction between CDDP and CSA/PEG/G nanocomposites.…”
Section: Drug Delivery From Nanocompositesmentioning
confidence: 99%